Workflow
Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions
TVGNTevogen Bio(TVGN) GlobeNewswire News Room·2024-10-15 18:30

Approximately one in three women remain HPV positive after cervical procedures for precancerous lesions. Tens of thousands of women in the US each year are diagnosed with high-grade cervical precancerous lesions. These high-grade cervical lesions can reoccur, requiring more treatment, and potentially lead to cervical cancer. Nearly all cervical cancer and high-grade cervical lesions are associated with HPV which promotes cancer formation. The primary risk factor for the recurrence of high-grade cervical les ...